Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending June 10, 2023 (Week 23)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 15,562 32,975 603,632 708,224
New England 742 1,472 19,334 22,014
Connecticut - 251 1,156 4,744
Maine 48 78 1,270 1,456
Massachusetts 489 723 12,928 11,967
New Hampshire 67 93 1,170 1,331
Rhode Island 105 687 2,212 1,973
Vermont 33 37 598 543
Middle Atlantic 2,401 4,267 74,704 84,042
New Jersey 548 744 10,837 14,622
New York (excluding New York City) 802 1,532 17,897 16,587
New York City - 1,457 22,007 28,314
Pennsylvania 1,051 1,234 23,963 24,519
East North Central 1,753 4,838 82,080 100,799
Illinois 68 1,517 21,232 31,185
Indiana 331 855 12,408 14,471
Michigan 231 975 13,940 18,811
Ohio 706 1,219 23,420 24,629
Wisconsin 417 560 11,080 11,703
West North Central 827 2,120 37,775 44,536
Iowa 193 334 6,012 6,631
Kansas 78 300 1,850 6,147
Minnesota 149 496 9,579 9,726
Missouri 343 730 13,610 13,983
Nebraska - 223 3,561 4,277
North Dakota - 92 1,017 1,591
South Dakota 64 125 2,146 2,181
South Atlantic 3,923 7,177 137,884 148,346
Delaware - 211 2,515 2,229
District of Columbia 80 191 3,649 3,524
Florida 1,784 2,789 49,520 44,502
Georgia 888 1,582 23,944 32,557
Maryland U NC U U
North Carolina 11 1,429 23,133 29,038
South Carolina 571 884 14,755 16,074
Virginia 576 984 18,551 18,430
West Virginia 13 110 1,817 1,992
East South Central 1,075 2,499 44,528 46,912
Alabama 593 972 15,129 13,504
Kentucky 302 511 6,886 7,759
Mississippi 121 526 7,718 8,420
Tennessee 59 1,092 14,795 17,229
West South Central 469 4,917 60,473 103,410
Arkansas 205 391 7,075 7,926
Louisiana 241 802 14,995 16,158
Oklahoma 23 422 4,525 8,821
Texas - 3,388 33,878 70,505
Mountain 1,335 2,490 45,530 50,406
Arizona 464 917 17,253 18,135
Colorado 389 787 11,858 10,982
Idaho 89 154 2,551 2,045
Montana 29 112 1,520 1,826
Nevada 124 361 3,375 7,083
New Mexico 6 262 3,391 4,663
Utah 234 246 4,870 4,926
Wyoming - 54 712 746
Pacific 3,037 5,046 101,324 107,759
Alaska 36 121 1,748 2,354
California 2,367 4,111 83,836 84,889
Hawaii - 3 - 60
Oregon 265 357 6,659 7,050
Washington 369 635 9,081 13,406
U.S. Territories - 112 881 1,720
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 112 881 1,720
U.S. Virgin Islands - 0 - -
Non-U.S. Residents - 7 22 57
Total 15,562 33,062 604,535 710,001
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.